Literature DB >> 1596977

Reconstituted thiopentone retains its alkalinity without bacterial contamination for up to four weeks.

C L Wong1, C B Warriner, J P McCormack, A M Clarke.   

Abstract

The manufacturers of thiopentone recommend that after reconstitution, it should be kept only for 24 hr to reduce the risk of contamination. However, there are no studies to support this practice and compliance with this recommendation has economic implications. The reasons for discarding a reconstituted bottle of thiopentone are related to concerns about chemical and physical (pH) stability, contamination with infectious agents, and contamination with cellular material. We studied the incidence of bacterial contamination and pH stability of thiopentone in clinical use, as well as the pH stability of thiopentone not in clinical use, and surveyed the eight hospitals affiliated with the University of British Columbia to determine their protocols for thiopental preparation and storage. Cost comparisons were made between our current practice of discarding thiopentone when depleted and the practice of routinely discarding it 24 hr after reconstitution. Samples of thiopentone in clinical use were cultured daily and the pH was measured. The bottles had been in clinical use from 1 to 25 days (mean 4.23 +/- 4.32 SD). Of 106 samples there were no positive bacteriological cultures and there were only minor changes in pH. The telephone survey of the eight hospitals revealed that only one had a policy to discard thiopentone after 24 hr. Cost comparisons indicate that discarding thiopentone 24 hr after reconstitution would result in increased cost. In conclusion, reconstituted thiopentone retains its alkalinity for up to four weeks, and has an acceptably low risk of bacterial contamination for periods beyond 24 hr, therefore thiopentone need not be discarded after 24 hr.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596977     DOI: 10.1007/BF03008717

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  12 in total

1.  Sterility of multiple dose vials after repeated use.

Authors:  J A YOUNG; T S COLLETTE; W F BREHM
Journal:  Am Surg       Date:  1958-11       Impact factor: 0.688

2.  Deterioration of solutions of pentothal sodium.

Authors:  M H ROBINSON
Journal:  Anesthesiology       Date:  1947-03       Impact factor: 7.892

3.  Program for bacterial surveillance of intravenous admixtures.

Authors:  R Ravin; J Bahr; F Luscomb; J Gooch; S Mutter; S D Spittell
Journal:  Am J Hosp Pharm       Date:  1974-04

4.  Monitoring contamination levels of in-use intravenous solutions using "total sample" techniques.

Authors:  A L Hanson; R M Shelley
Journal:  Am J Hosp Pharm       Date:  1974-08

5.  Contamination of multiple-dose vials due to repeat use of syringes.

Authors: 
Journal:  CMAJ       Date:  1989-03-01       Impact factor: 8.262

6.  Hepatitis B virus transmission associated with a multiple-dose vial in a hemodialysis unit.

Authors:  M J Alter; J Ahtone; J E Maynard
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

7.  Sterility and use patterns of multiple-dose vials.

Authors:  J C Bawden; J A Jacobson; J C Jackson; R K Anderson; J P Burke
Journal:  Am J Hosp Pharm       Date:  1982-02

8.  Growth of nosocomial pathogens in multiple-dose parenteral medication vials.

Authors:  A K Highsmith; G P Greenhood; J R Allen
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

9.  Multidose medication vial sterility: an in-use study and a review of the literature.

Authors:  R Longfield; J Longfield; L P Smith; K C Hyams; M E Strohmer
Journal:  Infect Control       Date:  1984-04

10.  The effect of pancuronium on the solubility of aqueous thiopentone.

Authors:  W D Morton; J Lerman
Journal:  Can J Anaesth       Date:  1987-01       Impact factor: 5.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.